Skip to content Skip to main menu
MENU
Rob Surgical
CONTACT
  • ENG
    • ESP
    • CAT
Rob Surgical
  • Home
  • About
    • Story
    • Leadership
    • Board Of Directors
    • Testimonials
    • Values
    • Certifications
    • Careers
  • Bitrack System
    • Innovation
    • Characteristics
    • Dynamic Fulcrum Point
    • Hybrid Surgery
    • Open Robotic Platform
    • Instruments
    • Tested
  • Hybrid Surgery
    • Discover the Benefits: Patient
    • Discover the Benefits: Surgeon
    • Discover the Benefits: Hospital
  • Media
  • Contact
  • Market Trends
  • Legal
    • Legal Warning
    • Privacy Policy
    • Cookies Policy
© Rob Surgical 2023. All rights reserved
  • +34 93 013 08 83
  • rss@robsurgical.com
  • Autovia de Castelldefels C-31
  • Km 190-5 (near Airport)
    08820 El Prat de Llobregat (Barcelona)
  • ENG
    • ESP
    • CAT
  • All
  • Bitrack System
  • News
  • Rob Surgical

ROB SURGICAL SHOWCASES ITS HYBRID SURGERY ROBOT AT MOBILE WORLD CONGRESS

News

Post navigation

← THE UNIVERSITAT DE GIRONA HAS AWARDED AN HONORIS CAUSA DOCTORATE TO
JOSEP AMAT I GIRBAU, CO-FOUNDER AND CSO OF ROB SURGICAL
rob surgical at mwc
February 27, 2023
News
Share

THE SURGERY OF THE FUTURE AT MWC23

  • After participating in several trade fairs and congresses in the sector, MWC23 will be the first occasion on which it will be possible to see and perform simulations of abdominal operations with the robot and the technological platform.
  • The Rob Surgical System improves the efficiency of current surgical robotics, allowing universalization of high-precision surgery, adapting to the needs of the patient and the surgeon.
  • The robot has already been technically validated and tested in animal models by specialists from the Mayo Clinic (United States) and the university hospitals Clínic, Vall d’Hebron and Germans Trias de Barcelona.

Barcelona, February 2023. – Rob Surgical is showcasing its equipment for the first time at MWC23, highlighting the healthcare sector’s need for technological advances adapted to the real needs of hospitals, surgeons and patients. Rob Surgical has been selected to be part of The Next Hospital, an area led by IAS Channel (The Netflix of surgeons) that hosts the 7 main trends in healthcare and technology.

The value proposition is based on three pillars: high precision and safety that benefits the patient, superior usability for the surgeon and a significant reduction in the total cost per surgery that benefits hospitals, as it does not require a dedicated operating theatre, requires fewer staff, no prior training and supports hybrid surgeries.

This last point is the differentiating factor from competitors, the possibility of performing hybrid surgeries, alternating manual manoeuvres and high-precision robot-assisted manoeuvres. All this thanks to the use of the same instruments and flexible robotics that allows the robot to intervene only in the most delicate parts, thus reducing the time and cost of each intervention.

Rob Surgical’s system improves on current robotics and offers an open, flexible platform consisting of a column of four arms that allow the movements of surgical instruments to be controlled with sub-millimetre precision.

The founding team is formed by Dr. Josep Amat, Dr. Alícia Casals, Dr. Manel Frigola and the entrepreneur Jaume Amat. Rob Surgical has raised more than 20 million between private investors and public funding, being Scranton Enterprises the lead investor.


Fira Gran Via (North Access), C/ Foc, 3708038, Barcelona 

The Next Hospital: Hall 6 Stand 6A43.

To arrange date and time:

Marissé Arrufat

marisse.arrufat@robsurgical.com

608 73 31 70


 

It might also interest you

THE UNIVERSITAT DE GIRONA HAS AWARDED AN HONORIS CAUSA DOCTORATE TO
JOSEP AMAT I GIRBAU, CO-FOUNDER AND CSO OF ROB SURGICAL
Proposed by the Department of Computer Architecture and Technology and...
Continue reading ...
June 9, 2022
News
ALICIA CASALS, CO-FOUNDER OF ROB SURGICAL,
HAS BEEN ELECTED CHAIR OF THE IEEE ROBOTICS AND AUTOMATION SOCIETY
Today is #WomenInScienceDay and we are excited to share good...
Continue reading ...
March 8, 2022
News
JAUME AMAT
ATTENDED AT MEDICA
Our CEO Jaume Amat Riera attended Compamed High-Tech Forum at MEDICA...
Continue reading ...
December 9, 2021
News
JAUME AMAT
ASISTIÓ A MEDICA
Nuestro CEO Jaume Amat Riera asistió al Compamed High-Tech Forum...
Continue reading ...
December 9, 2021
Bitrack System, News
JOSEP AMAT,
CHIEF SCIENTIFIC OFFICER OF ROB SURGICAL, AWARDED THE CREU DE SANT JORDI
The Catalan Government has awarded the Creu de Sant Jordi 2020 to...
Continue reading ...
May 5, 2020
News
SEE ALL MEDIA
Rob Surgical
  • +34 93 013 08 83
  • rss@robsurgical.com
  • Autovia de Castelldefels C-31
    Km 190-5 (near Airport)
    08820 El Prat de Llobregat (Barcelona)

Sign up to our newsletter

* Required fields:
Data controller: ROB SURGICAL.
Purpose: To manage the sending of electronic newsletters about ROB SURGICAL products, services and activities.
Legitimation: Consent of the data subject.
Recipients: Service providers outside of the European Union that offer appropriate guarantees concerning data protection.
Rights: Access, rectification and erasure, as well as the other rights listed in the additional information section.
Additional information: You can find additional detailed information about how ROB SURGICAL processes your data in the Privacy Policy

You’ve been successfully subscribed to our newsletter!

© 2023 Rob Surgical. All rights reserved Terms and conditions
  • Home
  • About
    • Story
    • Leadership
    • Board Of Directors
    • Testimonials
    • Values
    • Certifications
    • Careers
  • Bitrack System
    • Innovation
    • Characteristics
    • Dynamic Fulcrum Point
    • Hybrid Surgery
    • Open Robotic Platform
    • Instruments
    • Tested
  • Hybrid Surgery
    • Discover the Beneits: Patient
    • Discover the Beneits: Surgeon
    • Discover the Beneits: Hospital
  • Market Trends
  • Contact
  • Media
  • Legal
    • Legal Warning
    • Privacy Policy
    • Cookies Policy
© 2023 Rob Surgical. All rights reserved Terms and conditions